Martingale Asset Management L P raised its stake in shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD – Free Report) by 9.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 51,412 shares of the company’s stock after buying an additional 4,307 shares during the period. Martingale Asset Management L P owned about 0.21% of Tactile Systems Technology worth $881,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of TCMD. Jones Financial Companies Lllp acquired a new stake in Tactile Systems Technology during the fourth quarter valued at $39,000. 1620 Investment Advisors Inc. purchased a new position in shares of Tactile Systems Technology in the 4th quarter valued at about $97,000. Legal & General Group Plc increased its stake in shares of Tactile Systems Technology by 33.2% in the 4th quarter. Legal & General Group Plc now owns 6,257 shares of the company’s stock valued at $107,000 after purchasing an additional 1,558 shares in the last quarter. AlphaQuest LLC acquired a new position in Tactile Systems Technology in the 4th quarter worth about $158,000. Finally, XTX Topco Ltd purchased a new position in Tactile Systems Technology during the third quarter worth approximately $163,000. Institutional investors and hedge funds own 83.43% of the company’s stock.
Insider Buying and Selling at Tactile Systems Technology
In other Tactile Systems Technology news, VP Kristie Burns sold 4,830 shares of Tactile Systems Technology stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $14.65, for a total value of $70,759.50. Following the completion of the transaction, the vice president now directly owns 84,008 shares of the company’s stock, valued at $1,230,717.20. The trade was a 5.44 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Elaine M. Birkemeyer sold 3,778 shares of the business’s stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $14.70, for a total transaction of $55,536.60. Following the sale, the chief financial officer now owns 104,098 shares in the company, valued at $1,530,240.60. This trade represents a 3.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 19,546 shares of company stock valued at $285,444 over the last 90 days. 0.96% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on TCMD
Tactile Systems Technology Stock Performance
NASDAQ:TCMD opened at $13.27 on Friday. The company has a current ratio of 4.36, a quick ratio of 3.80 and a debt-to-equity ratio of 0.11. The company’s 50-day moving average price is $14.47 and its 200-day moving average price is $15.75. Tactile Systems Technology, Inc. has a twelve month low of $11.12 and a twelve month high of $21.10. The company has a market cap of $314.05 million, a P/E ratio of 18.96 and a beta of 1.21.
Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) last announced its quarterly earnings results on Tuesday, February 18th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.31 by $0.09. The business had revenue of $85.59 million during the quarter, compared to the consensus estimate of $85.39 million. Tactile Systems Technology had a net margin of 5.79% and a return on equity of 9.37%. On average, sell-side analysts forecast that Tactile Systems Technology, Inc. will post 0.7 earnings per share for the current fiscal year.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Further Reading
- Five stocks we like better than Tactile Systems Technology
- Profitably Trade Stocks at 52-Week Highs
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- How to Calculate Stock Profit
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.